{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "ABERA BIOSCIENCE AB", "longName": "Abera Bioscience AB", "messageBoardId": "finmb_260899884", "market": "dr_market", "marketState": "REGULAR", "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.14, "sharesOutstanding": 12907900, "fiftyDayAverage": 0.40932, "fiftyDayAverageChange": -0.022320002, "fiftyDayAverageChangePercent": -0.05452947, "twoHundredDayAverage": 0.4521275, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "regularMarketChangePercent": -3.0075176, "regularMarketPrice": 0.387, "regularMarketChange": -0.0119999945, "regularMarketTime": 1683875702, "regularMarketDayHigh": 0.387, "regularMarketDayRange": "0.387 - 0.387", "regularMarketDayLow": 0.387, "regularMarketPreviousClose": 0.399, "bid": 0.395, "ask": 0.457, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.387, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.081, "fiftyTwoWeekLowChangePercent": 0.2647059, "fiftyTwoWeekRange": "0.306 - 0.88", "fiftyTwoWeekHighChange": -0.493, "fiftyTwoWeekHighChangePercent": -0.5602273, "fiftyTwoWeekLow": 0.306, "fiftyTwoWeekHigh": 0.88, "twoHundredDayAverageChange": -0.06512749, "twoHundredDayAverageChangePercent": -0.14404674, "marketCap": 5854961, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "firstTradeDateMilliseconds": 1620280800000, "priceHint": 4, "symbol": "8WK.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Dragarbrunnsgatan 45", "address2": "Box 1747", "city": "Uppsala", "zip": "751 47", "country": "Sweden", "phone": "46 7 04 33 04 49", "website": "https://aberabio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Abera Bioscience AB, a platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally. The company's development platform named BERA, uses for the display of antigens at the surface of outer membrane vesicles derived from genetically optimized gram-negative bacteria. It also develops clinical phase universal pneumococcal vaccine; and projects in immuno-oncology, Chlamydia, ETEC, Covid-19, and Tuberculosis. Abera Bioscience AB was incorporated in 2012 and is based in Stockholm, Sweden.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Anders  Ericsson", "age": 52, "title": "Exec. Chairman of Board", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Maria  Alriksson", "age": 39, "title": "Chief Exec. Officer", "yearBorn": 1983, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Associate Prof. Joen  Luirink", "age": 62, "title": "Co-Founder & CTO", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mats  Lundgren", "age": 57, "title": "VP of R&D and CSO", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}